SCHEMBL14907798

SCHEMBL14907798

COC(=O)c1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 0.61
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
TNKS O95271 1/20 0.45
HPGD P15428 3/20 0.45
LMNA P02545 2/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
PKM P14618 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 4/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
RHEB Q15382 1/20 0.43
RAF1 P04049 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18540538 0.90 GRK6 (0.49) GRK6ALDH1A1KDM4ETNKSHPGD
SCHEMBL21763932 0.84 TDP1 (0.46) GRK6ALDH1A1HPGDMAPTKMT2A
SCHEMBL16171165 0.83 KMT2A (0.45) GRK6ALDH1A1KDM4EHPGDLMNA
SCHEMBL11887741 0.82 TYMP (0.57) GRK6ALDH1A1KDM4EHPGDMAPT
SCHEMBL19425608 0.80 TYMP (0.57) GRK6KDM4ERAB9AMAPTKMT2A
SCHEMBL14907826 0.79 GRK6 (0.60) GRK6ALDH1A1KDM4ERAB9AKMT2A
SCHEMBL14907846 0.79 MAPT (0.48) GRK6ALDH1A1KDM4ERAB9ANPC1
SCHEMBL6408622 0.79 GRK6 (0.62) GRK6KDM4EMAPT
SCHEMBL17214856 0.78 MAP3K8 (0.50) GRK6ALDH1A1KDM4EHPGDLMNA
SCHEMBL23527298 0.77 TSHR (0.57) ALDH1A1HPGDLMNARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134390-B1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUND MEDICAL EDUCATION & RES (US) 2020-02-26 EP disclosed
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed
WO-2015164415-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-10-29 WO disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES GRK6, GRK2, GRK3 GRK6 1/4885ALDH1A1 4745/4885KDM4E 4539/4885
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885ALDH1A1 4731/4885KDM4E 4504/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885ALDH1A1 4731/4885KDM4E 4504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.